StockData
Valion Bio, Inc. logo

Valion Bio, Inc. (VBIO) stock

VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.53+0.02 (+4.05%)

Close on Nov 13, 2026Market cap $2.20MP/E –Yield –

Valion Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Valion Bio's market cap was $2.09M on Nov 11, 2026, against $75.46M a year earlier. Over the last 5 years it ranged from $2.09M to $546.53M, with a median of $55.93M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.09M-96.5%
2025Dec 31, 2025$60.28M+11.5%
2024Dec 31, 2024$54.04M-18.1%
2023Dec 29, 2023$65.98M-57.4%
2022Dec 30, 2022$154.83M–

More Valion Bio figures

See a number that looks wrong?